More Related Content
Similar to Ist scientific possibilities_200911_web
Similar to Ist scientific possibilities_200911_web (20)
Ist scientific possibilities_200911_web
- 3. Stratify your patients with
thousands of others
Hundreds of patients
High
Medium Resistant for therapy?
Worst prognosis?
Low
Best prognosis?
Genomic signature for chromosomal instability
Data from
your patiens?
Copyright © 2011 MediSapiens Ltd. All rights reserved. • medisapiens.com
- 4. New therapy target for Ewing’s sarcoma?
Copyright © 2011 MediSapiens Ltd. All rights reserved. • medisapiens.com
- 5. Novel breast cancer associated gene
Only three publications in PubMed
(none brca associated)
Copyright © 2011 MediSapiens Ltd. All rights reserved. • medisapiens.com
- 7. Key EMT regulator and
miRNA target in Brca
Copyright © 2011 MediSapiens Ltd. All rights reserved. • medisapiens.com
- 8. Nearly unknown MMP related gene
Copyright © 2011 MediSapiens Ltd. All rights reserved. • medisapiens.com
- 9. Known cell cycle player – new target
for Burkitt’s lymphoma therapy?
Copyright © 2011 MediSapiens Ltd. All rights reserved. • medisapiens.com
- 10. Significant subsets of patients in multiple cancers
for a known phosphatase downstream of KRAS
Copyright © 2011 MediSapiens Ltd. All rights reserved. • medisapiens.com
- 11. Are you sure your model actually
models the cancer you study?
Here we see three
commonly used
melanoma cell lines,
and how their gene
expression matches
actual in vivo samples,
with regards to
melanoma specific
genes.
We have a patent
pending algorithm*
that enables you to
compare your samples
with over 15 000 fully
annotated cancer
* Kilpinen et al. BioData Mining 2011, 4:5 Ojala et. al. Genome Medicine, In Press samples.
Copyright © 2011 MediSapiens Ltd. All rights reserved. • medisapiens.com
- 13. MediSapiens Ltd.
Biomedicum Helsinki +358 50 363 1848
Tukholmankatu 8A contact@medisapiens.com
FIN-00290 Helsinki medisapiens.com
Copyright © 2011 MediSapiens Ltd. All rights reserved. • www.medisapiens.com
